Fifteen-year Outcomes of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer: The Long-term MGH Experience

Abstract

We report long-term outcomes of patients with muscle-invasive bladder cancer treated on prospective protocols with combined modality therapy (transurethral resection bladder tumor [TURBT], radiation therapy [RT], chemotherapy).